Almonty: A 10% Slide, a $19 Target, and Why a Ramp-Up Isn't a Catalyst
Published on 10/20/2026 at 13:31 | Editorial boerse-global.de
Almonty's shares fell 10% in a single session following its investor day, a move that says less about the mines themselves than about what the market had been hoping to hear. Management confirmed operational progress but offered no fresh catalyst, and with risk appetite thinning across the metals sector, investors chose to bank gains rather than wait for more.
That distinction — between a business advancing and a stock being repriced — sits at the heart of how the tungsten producer should be read right now. The two are not the same thing, and conflating them leads to faulty conclusions in either direction.
Progress Comes in Different Stages of Readiness
A summary of the event places Sangdong in the middle of its ramp-up. For the second expansion phase, equipment orders are being placed and underground planning is under way. Almonty is also weighing a facility for APT or oxide.
Each of those statements describes a different level of maturity. A ramp-up already in motion is not the same as preparation for an expansion, and a facility under consideration is not an approved project. Bundling all three under the heading of "growth" blurs precisely the distinctions that matter when conviction is in short supply.
Should investors sell immediately? Or is it worth buying Almonty?
In a market with reduced risk tolerance, that gap becomes consequential. The announcements carry operational promise, but promise alone does not automatically reset a valuation. The reported share-price reaction reads more like disappointment over the absence of additional triggers than evidence of any operational setback. A falling price describes how investors responded; it does not establish that a mine is running worse or that an expansion plan has changed.
Two Explanations, Kept Separate
The analyst move on Thursday fits the same pattern. Ian Zaffino of Oppenheimer cut his price target to $19 from $25, citing lower valuation multiples among comparable companies, while keeping his positive rating on the stock. The reasoning deserves more attention than the number itself: a reduced valuation yardstick can alter how a share is priced without overturning the underlying investment case.
There is a second thread running alongside it. Chinese tungsten prices fell sharply in October, with media reports pointing to inventory-cycle pressures and a shift toward liquidity. That is an industry backdrop, not a fresh company disclosure — and it should not be confused with the reason for the target cut, which was explicitly tied to peer multiples.
Almonty at a turning point? This analysis reveals what investors need to know now.
What Actually Matters From Here
Neither story alone captures Almonty. It is not purely a tale of operational milestones, nor merely a mirror of the tungsten price. The recent weakness unfolded against a softer sector environment, and the investor day's content was weighed against expectations that had already run ahead of it.
For shareholders, the question is whether the ramp-up, the expansion preparations and the proposed processing facility start moving in the same direction as commodity conditions — and whether each new disclosure carries enough genuinely new information to justify a higher multiple.
Ad
Almonty Stock: New Analysis - 20 October
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
